Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes.

Dounel J, Díaz LA, Bettencourt R, Tavaglione F, Madamba E, Richards L, Loomba R, Ajmera V

Open source

DOI
10.1016/j.gastha.2026.101022
Published
2026
Container
Gastro hep advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.gastha.2026.101022,
  title = {Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes.},
  author = {Dounel J and Díaz LA and Bettencourt R and Tavaglione F and Madamba E and Richards L and Loomba R and Ajmera V},
  year = {2026},
  journal = {Gastro hep advances},
  doi = {10.1016/j.gastha.2026.101022},
  url = {https://doi.org/10.1016/j.gastha.2026.101022}
}

RIS

TY  - JOUR
TI  - Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes.
AU  - Dounel J
AU  - Díaz LA
AU  - Bettencourt R
AU  - Tavaglione F
AU  - Madamba E
AU  - Richards L
AU  - Loomba R
AU  - Ajmera V
PY  - 2026
JO  - Gastro hep advances
DO  - 10.1016/j.gastha.2026.101022
UR  - https://doi.org/10.1016/j.gastha.2026.101022
ER  - 

APA

J, D., LA, D., R, B., F, T., E, M., L, R., R, L., & V, A. (2026). Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes.. Gastro hep advances. https://doi.org/10.1016/j.gastha.2026.101022

Source records